Discover how Dr. José Manuel Pioner uses LunaGel™ for 3D cardiac tissue engineering, advancing genetic cardiomyopathy research at the University of Florence.
NIH Ends Funding for Animal‑Only Studies: What This Means for Biomedical Research and 3D Cell Culture The National Institutes of Health (NIH) has announced a major policy change: ending funding for research projects based solely on animal studies. Moving forward, all NIH grant applications must include non-animal methods (NAMs) such as 3D cell culture models, […]
Empowering Dr. Silvia Cometta’s Innovations in Implant Safety and Biofilm Research with Gelomics’ Technology In the bustling research labs of the Queensland University of Technology, Dr. Silvia Cometta and her team are at the forefront of biomedical engineering, specifically focusing on the persistent challenge of biofilm infections on medical implants. With a rich background in […]
Gelomics Achieves Triple ISO Certification, Reinforcing Global Leadership in Biomedical Innovation We’re proud to share an exciting milestone for the Gelomics team: we’ve officially been awarded ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications! These internationally recognized standards reflect our commitment to quality, environmental responsibility, and the health and safety of our team. The […]
Gelomics Partners with Morpho Biotech for Benelux Distribution At Gelomics, we are committed to making cutting-edge, animal-free research tools more accessible to scientists around the globe. Today, we’re excited to announce a new strategic partnership with Morpho Biotech, who will serve as the exclusive distributor of Gelomics products in the Netherlands, Belgium, and Luxembourg (Benelux) […]
Gelomics Partners with BioNordika Group to Expand Presence Across the Nordics and Baltics We’re excited to announce that Gelomics is now a registered supplier on BioNordika! Our cutting-edge 3D cell culture technologies are now accessible to researchers across the Nordic and Baltic regions. BioNordika is a trusted distributor representing a wide range of world-leading and […]
Gelomics Welcomes Distinguished Professor Gail Risbridger to its Scientific Advisory Board Gelomics, a pioneering Australian biotech firm redefining the future of drug development with its cutting-edge 3D tissue culture technologies, is delighted to announce the appointment of Distinguished Professor Gail Risbridger AM to its Scientific Advisory Board. Professor Risbridger joins a team of internationally recognized […]
Watch Gelomics’ latest on-demand Webinar! Join Emma Morris as she explores the future of 3D cell culture in this exclusive webinar. Discover how LunaGel™ is transforming cell-based assays with enhanced reproducibility, tunable stiffness, and complete customization—offering a powerful alternative to traditional ECMs like Matrigel. Book a meeting with Gelomics’ Sales and Applications Specialist Emma Morris.
Gelomics Now Available on Scientist.com We are excited to announce that Gelomics is now a supplier on Scientist.com! Through this leading platform for scientific sourcing, we are providing simple, fast and reliable access to our innovative 3D tissue culture products and services in the US. Why choose Gelomics on Scientist.com? Since 2007, Scientist.com has become […]
